Overview of docetaxel (Taxotere)/cisplatin combination in non-small cell lung cancer

被引：1
|
作者：
Le Chevalier, T
Bérille, J
Zalcberg, JR
Millward, MJ
Monnier, A
Douillard, JY
McKeage, MJ
James, R
Soulas, F
Loret, C
Bougon, N
Bizzari, JP
机构：
[1] Inst Gustave Roussy, Dept Med, F-94805 Villejuif, France
[2] Rhone Poulenc Rorer, Antony, France
[3] Heidelberg Repatriat Hosp, Heidelberg, Vic, Australia
[4] Peter MacCallum Canc Inst, E Melbourne, Australia
[5] CHG A Boulloche, Montbeliard, France
[6] Prince Wales Hosp, Randwick, NSW 2031, Australia
[7] Rhone Poulenc Rorer, Melbourne, Vic, Australia
来源：
SEMINARS IN ONCOLOGY | 1999年 / 26卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：13 / 18
页数：6
相关论文
共 50 条
  • [21] Docetaxel (Taxotere) in non-small cell lung cancer: Ongoing studies in Heidelberg and future plans
    Manegold, C
    [J]. SEMINARS IN ONCOLOGY, 1999, 26 (03) : 23 - 27
  • [22] Docetaxel (Taxotere) in the treatment of non-small cell lung cancer: Recent results and future developments
    Rosell, R
    [J]. SEMINARS IN ONCOLOGY, 1999, 26 (03) : 1 - 3
  • [23] Docetaxel (Taxotere®) and Carboplatin in the treatment of advanced non-small lung cancer (NSCLC)
    Schutte, W
    Bork, I
    Wollschlager, B
    Schadlich, S
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 90 - 90
  • [24] Intrapleural combination bevacizumab with cisplatin therapy for non-small cell lung cancer caused by non-small cell lung cancer
    Du, Nan
    Zhao, Hui
    Wang, Haibin
    Li, Xiaosong
    Ma, Junxun
    Fan, Zhongyi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [25] Docetaxel and non-small cell lung cancer
    Le Guen, Y
    Le Cesne, A
    [J]. BULLETIN DU CANCER, 2004, 91 (03) : 263 - 270
  • [26] A comparative study of combination chemotherapy with docetaxel/cisplatin versus gemcitabine/cisplatin for locally advanced non-small cell lung cancer
    El-Nashar, E
    [J]. LUNG CANCER, 2005, 49 : S243 - S243
  • [27] Cisplatin plus docetaxel combination in the first-line treatment of metastatic non-small cell lung cancer
    Kaya, Ali Osman
    Buyukberber, Suleyman
    Dane, Faysal
    Isikdogan, Abdurrahman
    Ustaalioglu, Basak Oven
    Coskun, Ugur
    Yumuk, Perran Fulden
    Dogu, Gamze Gokoz
    Ozdemir, Nuriye Yildirim
    Sevinc, Alper
    Gumus, Mahmut
    Ozkan, Metin
    Yildiz, Ramazan
    Ozturk, Banu
    Yaman, Emel
    Benekli, Mustafa
    [J]. TUMORI JOURNAL, 2010, 96 (03): : 400 - 404
  • [28] Phase I trial of motexafin gadolinium in combination with docetaxel and cisplatin for the treatment of non-small cell lung cancer
    William, William N.
    Zinner, Ralph G.
    Karp, Daniel D.
    Oh, Yun W.
    Glisson, Bonnie S.
    Phan, See-Chun
    Stewart, David J.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : 745 - 750
  • [29] Challenging the platinum combinations: Docetaxel (Taxotere) combined with gemcitabine or vinorelbine in non-small cell lung cancer
    Georgoulias, V
    Scagliotti, G
    Miller, V
    Eckardt, J
    Douillard, JY
    Manegold, C
    [J]. SEMINARS IN ONCOLOGY, 2001, 28 (01) : 15 - 21
  • [30] Docetaxel (Taxotere®) as first-line therapy of advanced non-small cell lung cancer (NSCLC)
    Manegold, C
    [J]. ONKOLOGIE, 2003, 26 : 26 - 32
12345